EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vericiguat protects against cardiac damage in a pig model of ischemia/reperfusion

Weida Zhu, Yue Ben, Yang Shen, Wenbing Liu iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0295566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Weida Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Cardiology, Yizheng Hospital of Nanjing Drum Tower Hospital Group, Yizheng, Jiangsu, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project of Nantong City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The purpose of this research was to verify that vericiguat, a soluble guanylate cyclase (sGC) stimulator, reduces myocardial ischemic reperfusion injury (MIRI), and to learn how this reduction happens. Methods and results To develop an ischaemia/reperfusion (I/R) model, the left anterior descending artery was blocked in minipigs under anesthesia for 90 minutes, followed by 180 minutes of reperfusion. Vericiguat is administered three hours before surgery. Two weeks after receiving therapy, pigs underwent cardiovascular magnetic resonance imaging (MRI) to evaluate the results. The MRI results suggest improvement in the myocardial infarct after vericiguat treatment. Vericiguat treatment for two weeks enhanced vascularity, inhibited pro-inflammatory cells, and decreased collagen deposition in the infarct zone of pigs. Short-term experiments investigating possible explanations have indicated that vericiguat has antiapoptotic effects on cardiomyocytes and increases levels of autophagy.

Conclusions

Vericiguat, an SGC activator, reduces MIRI in pigs by boosting autophagy, preventing apoptosis, and promoting angiogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionMyocardial Reperfusion InjurySwineAnimalsSwine, MiniatureMyocytes, CardiacReperfusionHeterocyclic Compounds, 2-RingPyrimidines

Substanzen

vericiguatHeterocyclic Compounds, 2-RingPyrimidines

Autor:innen und Institutionen

  • The Department of Cardiology, Yizheng Hospital of Nanjing Drum Tower Hospital Group, Yizheng, Jiangsu, China.
  • The Department of Cardiology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Department of Cardiovascular Medicine, Affiliated Maternity and Child Health Care Hospital of Nantong University, Nantong, Jiangsu, China.

ORCID-Profile: Wenbing Liu

Förderung

  • Science and Technology Project of Nantong City

Zitieren

APA

Zhu, W., Ben, Y., Shen, Y., & Liu, W. (2023). Vericiguat protects against cardiac damage in a pig model of ischemia/reperfusion. PLOS ONE. https://doi.org/10.1371/journal.pone.0295566

Vancouver

Zhu W, Ben Y, Shen Y, Liu W. Vericiguat protects against cardiac damage in a pig model of ischemia/reperfusion. PLOS ONE. 2023. doi:10.1371/journal.pone.0295566

BibTeX
@article{Zhu2023,
  author = {Zhu, Weida and Ben, Yue and Shen, Yang and Liu, Wenbing},
  title = {Vericiguat protects against cardiac damage in a pig model of ischemia/reperfusion},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0295566}
}
Kostenlos starten →